Novo Holdings A/S - 14 Sep 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel of Novo Holdings A/S
Issuer symbol
EWTX
Transactions as of
14 Sep 2022
Net transactions value
+$4,999,999
Form type
4
Filing time
16 Sep 2022, 14:35:28 UTC
Previous filing
22 Jul 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX COMMON STOCK Purchase $4,999,999 +484,496 +8.7% $10.32 6,071,703 14 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents a purchase from the underwriters in the Issuer's public offering.